Rankings
▼
Calendar
PRME (Prime Medicine, Inc.) Stock Financials & Earnings | Market Cap Arena
PRME
Prime Medicine, Inc.
Mkt Cap
$771M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$5M
Net Income (TTM)
-$201M
EPS (TTM)
-$1.35
Free Cash Flow (TTM)
-$167M
Gross Margin
0.0%
Op. Margin
-4498.1%
Net Margin
-4342.4%
FCF Margin
-3607.4%
P/S Ratio (TTM)
166.4x
P/E Ratio (TTM)
—
YoY Rev Growth
+55.3%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$40M
Q2 23
$0
$0
-$45M
Q3 23
$0
$0
-$51M
Q4 23
$0
$0
-$68M
Q1 24
$591K
-$724K
-$48M
Q2 24
$0
$0
-$56M
Q3 24
$209K
$209K
-$54M
Q4 24
$2M
$2M
-$44M
Q1 25
$1M
$1M
-$52M
Q2 25
$1M
-$749K
-$53M
Q3 25
$1M
-$43M
-$54M
Q4 25
$838K
$42M
-$49M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
1304.2x
—
Q2 24
1304.2x
—
Q3 24
963.5x
—
Q4 24
258.4x
—
Q1 25
200.4x
—
Q2 25
155.4x
—
Q3 25
129.0x
—
Q4 25
166.4x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$42M
-$44M
Q2 23
-$41M
-$43M
Q3 23
-$39M
-$42M
Q4 23
-$44M
-$46M
Q1 24
-$68M
-$70M
Q2 24
-$45M
-$47M
Q3 24
-$26M
-$27M
Q4 24
$16M
$14M
Q1 25
-$49M
-$51M
Q2 25
-$41M
-$43M
Q3 25
-$35M
-$35M
Q4 25
-$37M
-$38M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$2M
Q3 23
$3M
Q4 23
$2M
Q1 24
$2M
Q2 24
$2M
Q3 24
$1M
Q4 24
$2M
Q1 25
$2M
Q2 25
$2M
Q3 25
$247K
Q4 25
$290K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+101.2%
Q2 23
—
+72.0%
Q3 23
—
+62.6%
Q4 23
—
+75.9%
Q1 24
—
+22.2%
Q2 24
—
+23.0%
Q3 24
—
+5.8%
Q4 24
—
-31.8%
Q1 25
+146.0%
+10.0%
Q2 25
—
-2.1%
Q3 25
+486.1%
+1.4%
Q4 25
-61.6%
+6.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$0
—
Q2 23
$0
—
Q3 23
$4M
—
Q4 23
$4M
—
Q1 24
$5M
881.4%
Q2 24
$0
—
Q3 24
$7M
3266.5%
Q4 24
$6M
272.1%
Q1 25
$6M
390.7%
Q2 25
$6M
567.3%
Q3 25
$13M
1040.6%
Q4 25
$5M
538.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$31M
$9M
Q2 23
$35M
$11M
Q3 23
$41M
$10M
Q4 23
$41M
$13M
Q1 24
$38M
$11M
Q2 24
$43M
$13M
Q3 24
$40M
$14M
Q4 24
$34M
$12M
Q1 25
$41M
$13M
Q2 25
$41M
$13M
Q3 25
$44M
$11M
Q4 25
$35M
$15M
marketcaparena.com
Revenue Segments
Reportable Segment
Quarter
Reportable Segment
Q1 25
$1M
Q2 25
$1M
Q3 25
$1M
Q4 25
$838K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$133M
$116M
$250M
Q2 23
$121M
$87M
$208M
Q3 23
$44M
$121M
$165M
Q4 23
$42M
$80M
$122M
Q1 24
$94M
$117M
$211M
Q2 24
$56M
$107M
$163M
Q3 24
$118M
$58M
$176M
Q4 24
$182M
$8M
$190M
Q1 25
$92M
$52M
$144M
Q2 25
$54M
$48M
$102M
Q3 25
$71M
$137M
$208M
Q4 25
$63M
$115M
$178M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
89M
-8.4%
Q2 23
90M
+1.6%
Q3 23
92M
+1.5%
Q4 23
97M
+6.0%
Q1 24
104M
+7.3%
Q2 24
119M
+14.1%
Q3 24
120M
+0.5%
Q4 24
119M
-1.0%
Q1 25
131M
+10.4%
Q2 25
129M
-1.3%
Q3 25
161M
+24.2%
Q4 25
149M
-7.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
$0
175
FY 23
$0
234
FY 24
$14K
214
FY 25
$46
100K
marketcaparena.com